Risk of non-bacterial opportunistic infections associated with janus kinase inhibitors versus tumor necrosis factor inhibitors among rheumatoid arthritis patients: A cohort study
Anna Shin, Ryan B Choi, Jung Yoon Pyo, You‐Jung Ha, Yun Jong Lee, Eun Bong Lee, Eun Ha Kang
IF 4.3Joint Bone Spine
키워드
MedicineHazard ratioInternal medicineRheumatoid arthritisProportional hazards modelCohortTofacitinibCumulative incidencePopulationCohort study